XOMA and Viracta Therapeutics’ Multi-License Milestone and Royalty Monetization Transaction

Martina Bellini
Tagged:

Paul Hastings LLP advised Xoma Corporation on the deal.Xoma Corporation, a biotechnology and pharmaceutical royalty aggregator announced its multi-license and milestone monetization transaction with Viracta Therapeutics. Under…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here